DrugCite
Search

EXCEDRIN EXTRA STRENGTH TABLETS

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Excedrin Extra Strength Tablets Adverse Events Reported to the FDA Over Time

How are Excedrin Extra Strength Tablets adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Excedrin Extra Strength Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Excedrin Extra Strength Tablets is flagged as the suspect drug causing the adverse event.

Most Common Excedrin Extra Strength Tablets Adverse Events Reported to the FDA

What are the most common Excedrin Extra Strength Tablets adverse events reported to the FDA?

Incorrect Drug Administration Durat...
126 (5.65%)
Underdose
101 (4.53%)
Dizziness
54 (2.42%)
Off Label Use
49 (2.2%)
Headache
45 (2.02%)
Malaise
45 (2.02%)
Drug Dependence
44 (1.97%)
Nausea
40 (1.79%)
Drug Ineffective
32 (1.43%)
Feeling Abnormal
31 (1.39%)
Vomiting
28 (1.26%)
Show More Show More
Dyspnoea
25 (1.12%)
Pain
25 (1.12%)
Abdominal Pain Upper
24 (1.08%)
Loss Of Consciousness
21 (.94%)
Diarrhoea
20 (.9%)
Hypersensitivity
20 (.9%)
Incorrect Dose Administered
20 (.9%)
Overdose
20 (.9%)
Blood Pressure Increased
17 (.76%)
Fatigue
17 (.76%)
Abdominal Discomfort
16 (.72%)
Cerebrovascular Accident
16 (.72%)
Drug Administration Error
15 (.67%)
Hypertension
15 (.67%)
Diabetes Mellitus
14 (.63%)
Inappropriate Schedule Of Drug Admi...
14 (.63%)
Rash
14 (.63%)
Therapeutic Response Unexpected
14 (.63%)
Chest Pain
13 (.58%)
Oedema Peripheral
13 (.58%)
Rebound Effect
13 (.58%)
Wrong Technique In Drug Usage Proce...
13 (.58%)
Arthritis
12 (.54%)
Fall
12 (.54%)
Hyperhidrosis
12 (.54%)
Infection
12 (.54%)
Ulcer
12 (.54%)
Abdominal Pain
11 (.49%)
Asthenia
11 (.49%)
Confusional State
11 (.49%)
Dyspepsia
11 (.49%)
Palpitations
11 (.49%)
Concomitant Disease Aggravated
10 (.45%)
Glaucoma
10 (.45%)
Hypoaesthesia
10 (.45%)
Road Traffic Accident
10 (.45%)
Tremor
10 (.45%)
Bronchitis
9 (.4%)
Chills
9 (.4%)
Gastric Disorder
9 (.4%)
Gastrooesophageal Reflux Disease
9 (.4%)
Myocardial Infarction
9 (.4%)
Pain In Extremity
9 (.4%)
Product Quality Issue
9 (.4%)
Prostate Cancer
9 (.4%)
Swelling Face
9 (.4%)
Withdrawal Syndrome
9 (.4%)
Asthma
8 (.36%)
Breast Cancer
8 (.36%)
Deafness
8 (.36%)
Death
8 (.36%)
Gastritis
8 (.36%)
Hiatus Hernia
8 (.36%)
Insomnia
8 (.36%)
Muscle Spasms
8 (.36%)
Pharyngeal Oedema
8 (.36%)
Swollen Tongue
8 (.36%)
Urticaria
8 (.36%)
Abdominal Distension
7 (.31%)
Anxiety
7 (.31%)
Back Injury
7 (.31%)
Blood Cholesterol Increased
7 (.31%)
Dependence
7 (.31%)
Disease Recurrence
7 (.31%)
Gastric Ulcer
7 (.31%)
Haemoglobin Decreased
7 (.31%)
Head Discomfort
7 (.31%)
Heart Rate Increased
7 (.31%)
Hypotension
7 (.31%)
Migraine
7 (.31%)
Pneumonia
7 (.31%)
Somnolence
7 (.31%)
Thrombosis
7 (.31%)
Amnesia
6 (.27%)
Cardiac Disorder
6 (.27%)
Convulsion
6 (.27%)
Disorientation
6 (.27%)
Dysgeusia
6 (.27%)
Gallbladder Disorder
6 (.27%)
Neoplasm
6 (.27%)
Osteoporosis
6 (.27%)
Swelling
6 (.27%)
Syncope
6 (.27%)
Arterial Occlusive Disease
5 (.22%)
Back Pain
5 (.22%)
Bladder Cancer
5 (.22%)
Blood Glucose Increased
5 (.22%)
Cataract
5 (.22%)
Cholelithiasis
5 (.22%)
Crying
5 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Excedrin Extra Strength Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Excedrin Extra Strength Tablets is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Excedrin Extra Strength Tablets

What are the most common Excedrin Extra Strength Tablets adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Excedrin Extra Strength Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Excedrin Extra Strength Tablets is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Excedrin Extra Strength Tablets According to Those Reporting Adverse Events

Why are people taking Excedrin Extra Strength Tablets, according to those reporting adverse events to the FDA?

Headache
217
Pain
82
Migraine
62
Back Pain
18
Arthritis
10
Prophylaxis
9
Show More Show More
Sinus Headache
6
Arthralgia
6
Osteoarthritis
5
Anticoagulant Therapy
5
Pain In Extremity
5
Tension Headache
4
Toothache
3
Asthenia
3
Somnolence
3
Fibromyalgia
2
Sinusitis
2
Back Disorder
1
Ear Pain
1
Malaise
1
Hangover
1
Tooth Abscess
1
Adnexa Uteri Pain
1
Product Used For Unknown Indication
1
Sciatica
1
Cardiac Disorder
1
Abdominal Pain Upper
1
Ulcer
1
Restless Legs Syndrome
1
Neuralgia
1
Hernia Pain
1
Pain Management
1
Sinus Disorder
1
Pain In Jaw
1
Dental Discomfort
1
Rheumatoid Arthritis
1
Temporomandibular Joint Syndrome
1
Influenza
1
Rhinitis
1
Hypersensitivity
1
Muscle Disorder
1
Intervertebral Disc Protrusion
1

Excedrin Extra Strength Tablets Case Reports

What Excedrin Extra Strength Tablets safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Excedrin Extra Strength Tablets. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Excedrin Extra Strength Tablets.